tradingkey.logo

Nxera Pharma Co Ltd - Nxera To Receive Us$4.8 Mn In Milestone Payments Following Centessa's Initiation Of Clinical Development Of Orx142, A Novel Ox2r Agonist

ReutersJul 4, 2025 12:02 AM

- Centessa Pharmaceuticals PLC 260y.F:

  • NXERA PHARMA CO LTD: NXERA TO RECEIVE US$4.8 MN IN MILESTONE PAYMENTS FOLLOWING CENTESSA'S INITIATION OF CLINICAL DEVELOPMENT OF ORX142, A NOVEL OX2R AGONIST

Further company coverage: [260y.F]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI